23 results
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
of the EMBRAVE study of elsunersen were presented at the American Epilepsy Society 2023 Annual Meeting, showing 43% median reduction in seizures; received … Epilepsies: At the American Epilepsy Society 2023 Annual Meeting, Praxis shared data from Part 1 of the EMBRAVE study, where four patients were dosed
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
28 Nov 22
Regulation FD Disclosure
8:04am
MOVEMENT IN 6-OHDA PARKINSON’S MODEL
19 PRIMARY ENDPOINT: Change from baseline to Day 77 in the International Parkinson and Movement Disorder Society (MDS
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
in the International Parkinson and Movement Disorder Society (MDS) Unified Parkinson’s Disease Rating Scale (UPDRS) Part III (motor examination) score
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
27 Apr 22
Regulation FD Disclosure
4:34pm
as the Chief Medical/Innovation Officer of the Epilepsy Foundation. Past president of the American Epilepsy Society; past Secretary of the American … Society of Experimental Neurotherapeutics. Recipient of the American Epilepsy Society Lennox Award (2017) and Service Award (2005), the Epilepsy
8-K
EX-99.1
fdhop8i3uqlzns7
28 Feb 22
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
6:06am
S-3ASR
qwjjal56 posl
3 Nov 21
Automatic shelf registration
5:08pm
424B4
5gneisa17 b7ygp
14 May 21
Prospectus supplement with pricing info
4:34pm
8-K
EX-99.1
pt2ucpt c3pphjgj3pfj
11 May 21
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results
8:11am
DRS
yaukx
18 Mar 21
Draft registration statement
12:00am
10-K
u2c80sy r7qrwyidl
17 Mar 21
Annual report
8:33am
10-Q
cjltnluld4g0tq9
23 Nov 20
Quarterly report
4:16pm
424B4
1pzo5e2x0hs z8fhj
16 Oct 20
Prospectus supplement with pricing info
4:02pm